TY  - GEN
AU  - Schwartz,G K
AU  - Ward,D
AU  - Saltz,L
AU  - Casper,E S
AU  - Spiess,T
AU  - Mullen,E
AU  - Woodworth,J
AU  - Venuti,R
AU  - Zervos,P
AU  - Storniolo,A M
AU  - Kelsen,D P
TI  - A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin
SN  - 1078-0432
PY  - 1999///0218
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Dose-Response Relationship, Drug
KW  - Doxorubicin
KW  - Drug Administration Schedule
KW  - Enzyme Inhibitors
KW  - Female
KW  - Humans
KW  - Infusions, Intravenous
KW  - Leukopenia
KW  - chemically induced
KW  - Male
KW  - Metabolic Clearance Rate
KW  - Middle Aged
KW  - Neoplasms
KW  - blood
KW  - Pilot Projects
KW  - Protein Kinase C
KW  - antagonists & inhibitors
KW  - Regression Analysis
KW  - Sphingosine
KW  - Thrombocytopenia
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
ER  -